These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 18025337)

  • 21. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilirubin appears to be the only independent variable affecting mortality on liver transplant waiting list if waiting time exceeds 1 year.
    Lee YM; Wai CT; Da Costa M; Lee KH; Sutedja D; Tan KC; Isaac J; Lim SG
    Transplant Proc; 2005 Dec; 37(10):4365-6. PubMed ID: 16387121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
    Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
    Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deaths on the liver transplant waiting list: an analysis of competing risks.
    Kim WR; Therneau TM; Benson JT; Kremers WK; Rosen CB; Gores GJ; Dickson ER
    Hepatology; 2006 Feb; 43(2):345-51. PubMed ID: 16440361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is MELD really the definitive score for liver allocation?
    Lladó L; Figueras J; Memba R; Xiol X; Baliellas C; Vázquez S; Ramos E; Torras J; Rafecas A; Fabregat J; Lama C; Jaurrieta E
    Liver Transpl; 2002 Sep; 8(9):795-8. PubMed ID: 12200780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
    Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
    Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characterization and survival of adult patients awaiting liver transplantation in Chile.
    Zapata R; Innocenti F; Sanhueza E; Humeres R; Rios H; Suarez L; Palacios JM; Rius M; Hepp J
    Transplant Proc; 2004; 36(6):1669-70. PubMed ID: 15350446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of MELD in the allocation of priority for liver transplantation candidates].
    Colmenero J; Castro-Narro G; Navasa M
    Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Access to adult liver transplantation in Canada: a survey and ethical analysis.
    Mullen MA; Kohut N; Sam M; Blendis L; Singer PA
    CMAJ; 1996 Feb; 154(3):337-42. PubMed ID: 8564903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The UNOS OPTN waiting list from 1988 to 1993.
    Edwards EB; Guo T; Breen TJ; Bowen GR; Daily OP
    Clin Transpl; 1993; ():71-83. PubMed ID: 7918197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum sodium predicts mortality in patients listed for liver transplantation.
    Biggins SW; Rodriguez HJ; Bacchetti P; Bass NM; Roberts JP; Terrault NA
    Hepatology; 2005 Jan; 41(1):32-9. PubMed ID: 15690479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.